Back to stocks
VNDA

VNDA

Vanda Pharmaceuticals Inc.• Healthcare

Q3 2026 filings are still coming in. 13F filers have 45 days after the quarter ends to report, through November 14, 2026. These totals cover only the funds that have filed so far and will keep rising.
Institutional holders
21
Partial Q3 2026
Total 13F value
$930K
Filed positions so far
New positions
1
This quarter
Sold positions
4
This quarter

Top holders

Institutions with disclosed positions in this stock

FundValueShares% PortfolioChange

Y-Intercept (Hong Kong) Ltd

$372K75.7K0.01%-74.3%

Harbor Capital Advisors, Inc.

$255K52.0K0.02%+1.2%

Wealth Enhancement Advisory Services, Llc

$204K45.0K0.00%-53.8%

Eastern Bank

$25K5.0K0.00%Unchanged

Farther Finance Advisors, Llc

$13K2.6K0.00%-12.4%

Versant Capital Management, Inc

$12K2.5K0.00%+2.4%

Gamma Investing Llc

$10K2.0K0.00%+592.4%

Essential Partners Llc

$8K1.6K0.00%-44.8%

Gf Fund Management Co. Ltd.

$7K1.3K0.00%+8.8%

Sjs Investment Consulting Inc.

$7K1.3K0.00%+259.1%

Sterling Capital Management Llc

$5K1.1K0.00%+1.9%

True Wealth Design, Llc

$4K7580.00%-42.9%

Ifp Advisors, Inc

$4K7510.00%-70.5%

Signaturefd, Llc

$3K5330.00%+6.8%

Root Financial Partners, Llc

$2K3730.00%New Position

Td Waterhouse Canada Inc.

$1K2940.00%Unchanged

Nisa Investment Advisors, Llc

$6921410.00%-58.6%

Fortitude Family Office, Llc

$319650.00%Unchanged

Cgc Financial Services, Llc

$246500.00%Unchanged

Sbi Securities Co., Ltd.

$59120.00%+20.0%

Ghp Investment Advisors, Inc.

$2040.00%Unchanged

Explore